Importantly, STAT3 can act as a negative feedback regulator, and targeted inhibition of STAT3 can enhance the efficacy of radiotherapy for head and neck cancer [48], lung cancer [49], and breast cancer [50]. This evidence concerns the gene STAT3 and head and neck cancer.